Comparison between internal jugular vein versus via axillary vein with single-incision for placement of implantable ports in cancer patients. Investigators are recruiting 240 patients and randomizing 120 for each arm. Primary outcome is early complications, until 30 days and secondary outcome late complications, between 30 days and 6 months. The follow-up is 12 months.

Prospective and randomized trial comparing internal jugular vein versus via axillary vein with single-incision for placement of implantable ports in cancer patients. Investigators are recruiting 240 patients and randomizing 120 for each arm in a single center study at AC Camargo Cancer Center. Every surgery is assisted by ultrasound and radioscopic and the catheter is districath®, 8.5 French. Clinical assessment will be at 10 days and every 3 months after surgery. Primary outcome is early complications, until 30 days and secondary outcome late complications, between 30 days and 6 months. The follow-up is 12 months.

Inclusion Criteria:

• Catheter due to chemotherapy.
• Cancer patients.
• ECOG (performance status) from 0 to 2.
• Signed informed consent form.

Exclusion Criteria:

• Non compliance.
• Anticoagulant therapy.
• Coagulopathy (platelet count below 50,000 and/or protrombin time above 18s).
• Death within 30 days after the procedure.
• Another catheter in superior vena cava.
• Previous long term catheter in superior vena cava.
• Obesity (IBM>40 Kg/m2).